Lefebvre P - Search Results

1

Adherence to First-Line Intravesical Bacillus Calmette-Guérin Therapy in the Context of Guideline Recommendations for US Patients With High-Risk Non-muscle Invasive Bladder Cancer.

Gaylis FD, Emond B, Manceur AM, Tardif-Samson A, Morrison L, Pilon D, Lefebvre P, Ellis LA, Balaji H, Ireland A. Gaylis FD, et al. Among authors: lefebvre p. J Health Econ Outcomes Res. 2024 Oct 28;11(2):109-117. doi: 10.36469/001c.124208. eCollection 2024. J Health Econ Outcomes Res. 2024. PMID: 39479557 Free PMC article.

2

Overall burden and impact on health-related quality of life associated with intravesical treatment of patients with non-muscle invasive bladder cancer in the United States.

Totev TI, Ireland A, Shah A, Tardif-Samson A, Lefebvre P, Pilon D. Totev TI, et al. Among authors: lefebvre p. Curr Med Res Opin. 2024 Nov;40(11):2003-2011. doi: 10.1080/03007995.2024.2411424. Epub 2024 Oct 7. Curr Med Res Opin. 2024. PMID: 39360373

3

Cost per median overall survival month associated with abiraterone acetate and enzalutamide for treatment of patients with metastatic castration-resistant prostate cancer.

Pilon D, Queener M, Lefebvre P, Ellis LA. Pilon D, et al. Among authors: lefebvre p. J Med Econ. 2016 Aug;19(8):777-84. doi: 10.3111/13696998.2016.1173042. Epub 2016 Apr 20. J Med Econ. 2016. PMID: 27031255 Free article.

4

Short-term rehospitalizations in young adults with schizophrenia treated with once-monthly paliperidone palmitate or oral atypical antipsychotics: a retrospective analysis.

Pilon D, Amos TB, Kamstra R, Manceur AM, El Khoury AC, Lefebvre P. Pilon D, et al. Among authors: lefebvre p. Curr Med Res Opin. 2019 Jan;35(1):41-49. doi: 10.1080/03007995.2018.1512477. Epub 2018 Sep 5. Curr Med Res Opin. 2019. PMID: 30106313

5

Real-world incidence of inflammatory bowel disease among patients with other chronic inflammatory diseases treated with interleukin-17a or phosphodiesterase 4 inhibitors.

Emond B, Ellis LA, Chakravarty SD, Ladouceur M, Lefebvre P. Emond B, et al. Among authors: lefebvre p. Curr Med Res Opin. 2019 Oct;35(10):1751-1759. doi: 10.1080/03007995.2019.1620713. Epub 2019 Jun 6. Curr Med Res Opin. 2019. PMID: 31106607

6

Burden of Crohn's disease in the United States: long-term healthcare and work-loss related costs.

Manceur AM, Ding Z, Muser E, Obando C, Voelker J, Pilon D, Kinkead F, Lafeuille MH, Lefebvre P. Manceur AM, et al. Among authors: lefebvre p. J Med Econ. 2020 Oct;23(10):1092-1101. doi: 10.1080/13696998.2020.1789649. Epub 2020 Jul 14. J Med Econ. 2020. PMID: 32609019 Free article.

7

Real-world treatment sequencing and healthcare costs among CLL/SLL patients treated with venetoclax.

Rogers KA, Emond B, Manceur AM, Kinkead F, Lafeuille MH, Lefebvre P, Huang Q. Rogers KA, et al. Among authors: lefebvre p. Curr Med Res Opin. 2021 Aug;37(8):1409-1420. doi: 10.1080/03007995.2021.1929894. Epub 2021 Jun 7. Curr Med Res Opin. 2021. PMID: 34003049 Free article.

8

Weight Change and Predictors of Weight Change Among Patients Initiated on Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide or Bictegravir/Emtricitabine/Tenofovir Alafenamide: A Real-World Retrospective Study.

Emond B, Rossi C, Côté-Sergent A, Dunn K, Lefebvre P, Lafeuille MH, Donga P. Emond B, et al. Among authors: lefebvre p. J Health Econ Outcomes Res. 2021 Jun 14;8(1):88-98. doi: 10.36469/001c.24535. J Health Econ Outcomes Res. 2021. PMID: 34179212 Free PMC article.

9

Real-World Analysis of Weight Gain and Body Mass Index Increase Among Patients with HIV-1 Using Antiretroviral Regimen Containing Tenofovir Alafenamide, Tenofovir Disoproxil Fumarate, or Neither in the United States.

Emond B, Rossi C, Rogers R, Lefebvre P, Lafeuille MH, Donga P. Emond B, et al. Among authors: lefebvre p. J Health Econ Outcomes Res. 2022 Feb 14;9(1):39-49. doi: 10.36469/jheor.2022.31825. eCollection 2022. J Health Econ Outcomes Res. 2022. PMID: 35233432 Free PMC article.

10

Total cost of testing for genomic alterations associated with next-generation sequencing versus polymerase chain reaction testing strategies among patients with metastatic non-small cell lung cancer.

Vanderpoel J, Stevens AL, Emond B, Lafeuille MH, Hilts A, Lefebvre P, Morrison L. Vanderpoel J, et al. Among authors: lefebvre p. J Med Econ. 2022 Jan-Dec;25(1):457-468. doi: 10.1080/13696998.2022.2053403. J Med Econ. 2022. PMID: 35289703 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,586 results

Search Page

Filters